ANTIEMETIC GUIDELINES: MASCC/ESMO Committee I (1/5): The Four Emetic Risk Groups HIGH Risk in nearly all patients (> 90%) MODERATERisk in 30% to 90% of patients LOWRisk in 10% to 30% of patients MINIMALFewer than 10% at risk
{}